| 1.4 |
4.1 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 1.2 |
3.5 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.8 |
5.1 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.6 |
2.8 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.5 |
3.8 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.3 |
0.9 |
GO:0086017 |
renin secretion into blood stream(GO:0002001) cell communication by chemical coupling(GO:0010643) Purkinje myocyte action potential(GO:0086017) regulation of renin secretion into blood stream(GO:1900133) |
| 0.3 |
2.0 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.2 |
0.6 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.2 |
0.5 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.2 |
0.8 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.2 |
0.8 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.2 |
1.6 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.2 |
0.6 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 |
3.9 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
0.4 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
| 0.1 |
0.4 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.1 |
0.6 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.8 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.1 |
1.3 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.8 |
GO:0071493 |
cellular response to UV-B(GO:0071493) replicative senescence(GO:0090399) |
| 0.1 |
2.3 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.1 |
0.4 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
1.9 |
GO:0071398 |
cellular response to fatty acid(GO:0071398) |
| 0.1 |
2.8 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
1.1 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 |
0.2 |
GO:1902524 |
negative regulation of interferon-alpha production(GO:0032687) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) negative regulation of interferon-beta biosynthetic process(GO:0045358) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.1 |
0.4 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.1 |
0.4 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 |
0.1 |
GO:1904173 |
regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
| 0.1 |
1.9 |
GO:1903077 |
negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.1 |
0.6 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
3.1 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.1 |
0.2 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.0 |
1.8 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.0 |
1.7 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.0 |
0.2 |
GO:0070295 |
renal water absorption(GO:0070295) |
| 0.0 |
0.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.2 |
GO:0071726 |
response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.0 |
0.2 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.0 |
0.7 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.0 |
0.5 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
1.8 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.0 |
0.9 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
1.1 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.7 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 |
0.4 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.7 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.2 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
1.1 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.0 |
0.8 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.0 |
0.1 |
GO:0001803 |
antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 0.0 |
0.1 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.0 |
0.0 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.0 |
0.7 |
GO:0051489 |
regulation of filopodium assembly(GO:0051489) |
